Skip to main content

New Products: Olink, Biognosys

Premium

Olink Bioscience this week launched its new Proseek Multiplex CVD protein biomarker panel.

Intended for research into cardiovascular disease, the panel allows for analysis of 92 CVD-related proteins across 96 samples simultaneously using as little as one microliter per sample, the company said. The panel uses Olink's Proseek Multiplex technology combined with Fluidigm's BioMark HD system.


Biognosys this week released a new version of its iRT kit for use in calibrating mass spec runs including shotgun and scheduled MRM experiments.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.